FIELD: pharmaceuticals; medicine.
SUBSTANCE: group of inventions relates to the field of pharmaceuticals and medicine. First invention represents a pharmaceutical composition for treating or preventing cancer, containing as an active substance a compound of formula 3a or 3b or its pharmaceutically acceptable salt and a pharmaceutically acceptable carrier:
,
.
Second invention of the group is a method for preventing or treating cancer, involving administering said composition. Third invention of the group is the use of said compounds for preventing or treating cancer.
EFFECT: group of inventions enables the prevention or treatment of cancer by using compounds capable of inhibiting the formation of the c-Myc/Max/DNA complex.
5 cl, 14 tbl, 4 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUND INHIBITING FORMATION OF C-MYC/MAX/DNA COMPLEX | 2017 |
|
RU2727177C1 |
| HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| NEW COMPOUND, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2814103C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
| NEW COMPOUND AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND FOR THE PREVENTION OR TREATMENT OF CANCER | 2020 |
|
RU2801811C1 |
| C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
| CONDENSED RING HETEROARYL COMPOUNDS AND USE THEREOF AS TRK INHIBITORS | 2015 |
|
RU2708674C2 |
| AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
